KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$4.6 million.

  • Cardlytics' Change in Receivables fell 34775.88% to -$4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.4 million, marking a year-over-year decrease of 34790.77%. This contributed to the annual value of -$12.5 million for FY2024, which is 26177.35% down from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Change in Receivables is -$4.6 million, which was down 34775.88% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Change in Receivables ranged from a high of $27.2 million in Q4 2021 and a low of -$21.4 million during Q1 2023
  • Its 5-year average for Change in Receivables is $679052.6, with a median of -$1.5 million in 2024.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 17609.49% in 2023, then crashed by 34775.88% in 2025.
  • Over the past 5 years, Cardlytics' Change in Receivables (Quarter) stood at $27.2 million in 2021, then fell by 27.78% to $19.6 million in 2022, then decreased by 4.65% to $18.7 million in 2023, then tumbled by 97.8% to $412000.0 in 2024, then crashed by 1226.94% to -$4.6 million in 2025.
  • Its Change in Receivables was -$4.6 million in Q3 2025, compared to -$2.6 million in Q2 2025 and -$7.5 million in Q1 2025.